HRTX vs IONS · rev $72.4M vs rev $514.0M
Heron Therapeuti (HRTX) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Heron Therapeuti (HRTX) is a biotechnology company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported HRTX revenue for 2026-06-30 was $72.4M. Net income was -$13.6M. HRTX currently screens at market cap $332.6M.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
HRTX currently screens at market cap $332.6M. IONS currently screens at market cap $12.28B.
Not investment advice. Open the HRTX and IONS stock pages for the full models.
Not investment advice.